A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.

Triple-negative breast cancer is associated with poor prognosis because of a high rate of tumor recurrence and metastasis. Previous studies demonstrated that the synthetic triterpenoid, CDDO-Imidazolide (CDDO-Im) induced cell cycle arrest and apoptosis in triple-negative breast cancer. Since a small...

Full description

Bibliographic Details
Main Authors: Jae Young So, Janice J Lin, Joseph Wahler, Karen T Liby, Michael B Sporn, Nanjoo Suh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4167992?pdf=render
_version_ 1819259733342683136
author Jae Young So
Janice J Lin
Joseph Wahler
Karen T Liby
Michael B Sporn
Nanjoo Suh
author_facet Jae Young So
Janice J Lin
Joseph Wahler
Karen T Liby
Michael B Sporn
Nanjoo Suh
author_sort Jae Young So
collection DOAJ
description Triple-negative breast cancer is associated with poor prognosis because of a high rate of tumor recurrence and metastasis. Previous studies demonstrated that the synthetic triterpenoid, CDDO-Imidazolide (CDDO-Im) induced cell cycle arrest and apoptosis in triple-negative breast cancer. Since a small subpopulation of cancer stem cells has been suggested to be responsible for drug resistance and metastasis of tumors, our present study determined whether the effects of CDDO-Im in triple-negative breast cancer are due to the inhibition of a cancer stem cell subpopulation. CDDO-Im treatment markedly induced cell cycle arrest at G2/M-phase and apoptosis in the triple-negative breast cancer cell lines, SUM159 and MDA-MB-231. Because SUM159 cells were more sensitive to CDDO-Im than MDA-MB-231 cells, the effects of CDDO-Im on the cancer stem cell subpopulation were further investigated in SUM159 cells. SUM159 cells formed tumorspheres in culture, and the cancer stem cell subpopulation, CD24-/EpCAM+ cells, was markedly enriched in SUM159 tumorspheres. The CD24-/EpCAM+ cells in SUM159 tumorspheres were significantly inhibited by CDDO-Im treatment. CDDO-Im also significantly decreased sphere forming efficiency and tumorsphere size in both primary and secondary sphere cultures. PCR array of stem cell signaling genes showed that expression levels of many key molecules in the stem cell signaling pathways, such as Notch, TGF-β/Smad, Hedgehog and Wnt, were significantly down-regulated by CDDO-Im in SUM159 tumorspheres. Protein levels of Notch receptors (c-Notch1, Notch1 and Notch3), TGF-β/Smad (pSmad2/3) and Hedgehog downstream effectors (GLI1) also were markedly reduced by CDDO-Im. In conclusion, the present study demonstrates that the synthetic triterpenoid, CDDO-Im, is a potent anti-cancer agent against triple-negative breast cancer cells by targeting the cancer stem cell subpopulation.
first_indexed 2024-12-23T19:14:42Z
format Article
id doaj.art-9112faeb1c7f460aa8e33b26a7002669
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:14:42Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9112faeb1c7f460aa8e33b26a70026692022-12-21T17:34:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10761610.1371/journal.pone.0107616A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.Jae Young SoJanice J LinJoseph WahlerKaren T LibyMichael B SpornNanjoo SuhTriple-negative breast cancer is associated with poor prognosis because of a high rate of tumor recurrence and metastasis. Previous studies demonstrated that the synthetic triterpenoid, CDDO-Imidazolide (CDDO-Im) induced cell cycle arrest and apoptosis in triple-negative breast cancer. Since a small subpopulation of cancer stem cells has been suggested to be responsible for drug resistance and metastasis of tumors, our present study determined whether the effects of CDDO-Im in triple-negative breast cancer are due to the inhibition of a cancer stem cell subpopulation. CDDO-Im treatment markedly induced cell cycle arrest at G2/M-phase and apoptosis in the triple-negative breast cancer cell lines, SUM159 and MDA-MB-231. Because SUM159 cells were more sensitive to CDDO-Im than MDA-MB-231 cells, the effects of CDDO-Im on the cancer stem cell subpopulation were further investigated in SUM159 cells. SUM159 cells formed tumorspheres in culture, and the cancer stem cell subpopulation, CD24-/EpCAM+ cells, was markedly enriched in SUM159 tumorspheres. The CD24-/EpCAM+ cells in SUM159 tumorspheres were significantly inhibited by CDDO-Im treatment. CDDO-Im also significantly decreased sphere forming efficiency and tumorsphere size in both primary and secondary sphere cultures. PCR array of stem cell signaling genes showed that expression levels of many key molecules in the stem cell signaling pathways, such as Notch, TGF-β/Smad, Hedgehog and Wnt, were significantly down-regulated by CDDO-Im in SUM159 tumorspheres. Protein levels of Notch receptors (c-Notch1, Notch1 and Notch3), TGF-β/Smad (pSmad2/3) and Hedgehog downstream effectors (GLI1) also were markedly reduced by CDDO-Im. In conclusion, the present study demonstrates that the synthetic triterpenoid, CDDO-Im, is a potent anti-cancer agent against triple-negative breast cancer cells by targeting the cancer stem cell subpopulation.http://europepmc.org/articles/PMC4167992?pdf=render
spellingShingle Jae Young So
Janice J Lin
Joseph Wahler
Karen T Liby
Michael B Sporn
Nanjoo Suh
A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
PLoS ONE
title A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
title_full A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
title_fullStr A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
title_full_unstemmed A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
title_short A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer.
title_sort synthetic triterpenoid cddo im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple negative breast cancer
url http://europepmc.org/articles/PMC4167992?pdf=render
work_keys_str_mv AT jaeyoungso asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT janicejlin asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT josephwahler asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT karentliby asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT michaelbsporn asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT nanjoosuh asynthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT jaeyoungso synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT janicejlin synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT josephwahler synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT karentliby synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT michaelbsporn synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer
AT nanjoosuh synthetictriterpenoidcddoiminhibitstumorsphereformationbyregulatingstemcellsignalingpathwaysintriplenegativebreastcancer